| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |